Learn about DARZALEX FASPRO® + VRd, the latest FDA-approved quad treatment combination for people with newly diagnosed multiple myeloma who are not eligible to receive a stem cell transplant

Sign Up For Support

DARZALEX FASPRO ® is now FDA approved as the first therapy for use alone to treat adults with high-risk smoldering multiple myeloma.

Homepage Banner Desktop Image
About DARZALEX FASPRO® & DARZALEX®
NextWhat are DARZALEX FASPRO® & DARZALEX®?

;